Ambulatory blood pressure monitoring in childhood and adult obesity

Current Hypertension Reports

Volumn 11, Issue 2, 2009, Pages 133-142

  Ben Dov, Iddo Z ^a   Bursztyn, Michael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CILAZAPRIL; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; PLACEBO; VERAPAMIL;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY FAT; BODY MASS; CHILD; CHILDHOOD DISEASE; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; GASTROPLASTY; GENETIC VARIABILITY; HUMAN; HYPERTENSION; INFORMATION RETRIEVAL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LOW CALORY DIET; OBESITY; REVIEW; SLEEP; SPHYGMOMANOMETRY; WAKEFULNESS; WEIGHT REDUCTION; WHITE COAT HYPERTENSION;

ADOLESCENT; ADULT; AGED; AROUSAL; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CHILD; CIRCADIAN RHYTHM; CROSS-CULTURAL COMPARISON; DIAGNOSIS, DIFFERENTIAL; DISEASES IN TWINS; HEART RATE; HUMANS; HYPERTENSION; INFANT; MIDDLE AGED; OBESITY; SENSITIVITY AND SPECIFICITY; WAIST-HIP RATIO; YOUNG ADULT;

EID: 62549161747     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0024-7     Document Type: Review

References (50)

1. Staessen J, O'Brien E, Atkins N, et al.: The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry. Am J Epidemiol 1992, 136:450-459.
2. Mancia G, Facchetti R, Bombelli M, et al.: Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005, 45:1072-1077.
3. Kotsis V, Stabouli S, Bouldin M, et al.: Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005, 45:602-607.
4. Kagan A, Faibel H, Ben Arie G, et al.: Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J Hum Hypertens 2007, 21:128-134.
5. Narkiewicz K, Gatti P, Garavelli G, et al.: Relation between family history of hypertension, overweight and ambulatory blood pressure: The HARVEST study. J Hum Hypertens 1995, 9:527-533.
6. Fagard R, Brguljan J, Staessen J, et al.: Heritability of conventional and ambulatory blood pressures: A study in twins. Hypertension 1995, 26:919-924.
7. Tiago AD, Samani NJ, Candy GP, et al.: Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002, 106:1483-1487.
8. Aihara A, Imai Y, Sekino M, et al.: Discrepancy between screening blood pressure and ambulatory blood pressure: A community-based study in Ohasama. Hypertens Res 1998, 21:127-136.
9. Manios ED, Koroboki EA, Tsivgoulis GK, et al.: Factors influencing white-coat effect. Am J Hypertens 2008, 21:153-158.
10. Verdecchia P, Palatini P, Schillaci G, et al.: Independent predictors of isolated clinic ("white-coat") hypertension. J Hypertens 2001, 19:1015-1020.
11. Kotsis V, Stabouli S, Toumanidis S, et al.: Target organ damage in "white coat hypertension" and "masked hypertension." Am J Hypertens 2008, 21:393-399.
12. Vinyoles E, Felip A, Pujol E, et al.: Clinical characteristics of isolated clinic hypertension. J Hypertens 2008, 26:438-445.
13. Gualdiero P, Niebauer J, Addison C, et al.: Clinical features, anthropometric characteristics, and racial influences on the "white-coat effect" in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Blood Press Monit 2000, 5:53-57.
14. Den Hond E, Celis H, Vandenhoven G, et al.: Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure. Blood Press Monit 2003, 8:37-40.
15. Ungar A, Pepe G, Monami M, et al.: Isolated ambulatory hypertension is common in outpatients referred to a hypertension centre. J Hum Hypertens 2004, 18:897-903.
16. Ben Dov IZ, Mekler J, Ben Arie L, Bursztyn M: Lack of association between body-mass index and white-coat hypertension among referred patients. Blood Press Monit 2007, 12:95-99.
17. Ben Dov IZ, Ben Ishay D, Mekler J, et al.: Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med 2007, 167:2139-2142.
18. Pierdomenico SD, Lapenna D, Bucci A, et al.: Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005, 18:1422-1428.
19. Hwang ES, Choi KJ, Kang DH, et al.: Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med 2007, 22:256-262.
20. Bobrie G, ClersAn P, Menard J, et al.: Masked hypertension: a systematic review. J Hypertens 2008, 26:1715-1725.
21. Obara T, Ohkubo T, Funahashi J, et al.: Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005, 23:1653-1660.
22. Mancia G, Bombelli M, Corrao G, et al.: Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: Daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007, 49:40-47.
23. Hassan MO, Jaju D, Albarwani S, et al.: Non-dipping blood pressure in the metabolic syndrome among Arabs of the Oman family study. Obesity (Silver Spring) 2007, 15:2445-2453.
24. Chamontin B, Amar J, Garelli-Flores I, Salvador M: Dippers and non-dippers among overweight hypertensive men. Blood Press Monit 1996, 1:329-332.
25. Diamantopoulos EJ, Andreadis E, Tsourous G, et al.: Insulin resistance and blood pressure circadian variation in an obese hypertensive population. Clin Exp Hypertens 2006, 28:625-630.
26. Ben Dov IZ, Kark JD, Ben Ishay D, et al.: Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med 2007, 167:2116-2121.
27. Guagnano MT, Ballone E, Merlitti D, et al.: Association between anthropometric and ultrasound measurements of fatness with ambulatory blood pressure monitoring in obese women. Int J Obes Relat Metab Disord 1997, 21:632-636.
28. Guagnano MT, Merlitti D, Murri R, et al.: Ambulatory blood pressure monitoring in evaluating the relationship between obesity and blood pressure. J Hum Hypertens 1994, 8:245-250.
29. Guagnano MT, Ballone E, Colagrande V, et al.: Large waist circumference and risk of hypertension. Int J Obes Relat Metab Disord 2001, 25:1360-1364.
30. Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT: Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002, 10:1203-1206.
31. Feldstein CA, Akopian M, Olivieri AO, et al.: A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: A hospital-based study. Nutr Metab Cardiovasc Dis 2005, 15:310-315.
32. Wühl E, Witte K, Soergel M, et al.: Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 2002, 20:1995-2007.
33. Li AQ, Zhao ZY, Zhang LL, et al.: Overweight influence on circadian variations of ambulatory blood pressure in Chinese adolescents. Clin Exp Hypertens 2005, 27:195-201.
34. Stabouli S, Kotsis V, Papamichael C, et al.: Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005, 147:651-656.
35. Lurbe E, Alvarez V, Liao Y, et al.: The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens 1998, 11:418-424.
36. Lurbe E, Alvarez V, Liao Y, et al.: Obesity modifies the relationship between ambulatory blood pressure and natriuresis in children. Blood Press Monit 2000, 5:275-280.
37. Lurbe E, Invitti C, Torro I, et al.: The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens 2006, 24:1557-1564.
38. Lurbe E, Torro I, Aguilar F, et al.: Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 2008, 51:635-641.
39. Gilardini L, Parati G, Sartorio A, et al.: Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008, 22:75-82.
40. Ruiz Pons M, Garcia Nieto V, Garcia MG, et al.: Reduced nocturnal systolic blood pressure dip in obese children. Nefrologia 2008, 28:517-524.
41. Marcovecchio ML, Patricelli L, Zito M, et al.: Ambulatory blood pressure monitoring in obese children: Role of insulin resistance. J Hypertens 2006, 24:2431-2436.
42. Minami J, Kawano Y, Ishimitsu T, et al.: Acute and chronic effects of a hypocaloric diet on 24-hour blood pressure, heart rate and heart-rate variability in mildly-to-moderately obese patients with essential hypertension. Clin Exp Hypertens 1999, 21:1413-1427.
43. Pekkarinen T, Takala I, Mustajoki P: Weight loss with very-low-calorie diet and cardiovascular risk factors in moderately obese women: One-year follow-up study including ambulatory blood pressure monitoring. Int J Obes Relat Metab Disord 1998, 22:661-666.
44. Laaksonen DE, Laitinen T, Schonberg J, et al.: Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens 2003, 21:371-378.
45. Bao DQ, Mori TA, Burke V, et al.: Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 1998, 32:710-717.
46. Van de Borne P, Watrin I, Bouquegneau M, et al.: Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery. J Hypertens 2000, 18:301-306.
47. White WB, Elliott WJ, Johnson MF, Black HR: Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hypertens 2001, 15:135-141.
48. Wofford MR, Anderson DC Jr, Brown CA, et al.: Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 2001, 14:694-698.
49. Rosa EC, Zanella MT, Kohlmann NE, et al.: Blood pressure and cardiorenal responses to antihypertensive therapy in obese women. Arq Bras Endocrinol Metabol 2008, 52:65-75.
50. Weir MR, Reisin E, Falkner B, et al.: Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. Am J Hypertens 1998, 11:914-920.